Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B Reply LANCET GASTROENTEROLOGY & HEPATOLOGY Tseng, C., Hsu, Y., Nguyen, M. H. 2021; 6 (2): 87–88

View details for Web of Science ID 000608617700016